AST’s Next-Generation Isolated GENiSYS C
Available for Quick Delivery
Available for quick delivery, AST’s Isolated GENiSYS C is a fully integrated solution for the production of high-value liquid pharmaceuticals. Leveraging the latest American-made turnkey technology from AST, this production system is backed by a localized, responsive model for supply and service.
The Isolated GENiSYS C is outfitted with AST’s Atmos isolator which features groundbreaking low-concentration hydrogen peroxide technology from CURIS System. This innovative low-volume, 7 percent Vapor Phase H2O2 solution utilizes patented Pulse™ technology for automated, precise biodecontamination protocols proven to achieve repeatable 6-log reduction or better. The only 7% VPHP system to be federally approved via tri-part soil load, AST’s barrier technology combines validated efficacy with complete cycle times (including aeration) of under 60 minutes.
Figure 1. The FIll/Close Module of the Isolated GENiSYS C
The new Atmos Isolator and the latest-generation GENiSYS C are two of AST’s intuitive, compact solutions that prioritize maximum yield and end-to-end product stewardship. Designed with superior flexibility and ultimate efficiency, these products are built to meet the multi-modal requirements of many of today’s parenteral drug manufacturers looking to keep their operational footprint small and their drug development process agile.
Features:
- Available for 6-month delivery
- Processes vials, syringes, and cartridges w/ minimal changeover time
- Flexible, compact isolator design
- 100-percent integration of fill-finish and barrier systems
- State-of-the-art automation
- Industry-leading biodecontamination cycle times
